Outcome after percutaneous closure of a patent foramen ovale using the Intrasept™ device: A multi-centre study

Justin G L M Luermans, Martijn C. Post, Rainer Schräder, Thierry Sluysmans, Tom Vydt, Paul Vermeersch, Massimo Chessa, Eustaquio Onorato, Jean Jacques Goy, Werner I H L Budts

Research output: Contribution to journalArticlepeer-review


Objectives: This multi-centre study reports safety and efficacy of percutaneous patent foramen ovale (PFO) closure, using the fourth generation Intrasept™ device. Background: PFO has been associated with paradoxical embolism and cryptogenic stroke. Percutaneous PFO closure seems to reduce the risk for recurrent paradoxical thromboembolism. Currently, different devices are used for PFO closure. Methods: Patients, who underwent a PFO closure with the Intrasept device (Cardia, Eagan, MN) between July 2002 and September 2006, were included in the study. The primary endpoint was defined as reoccurrence of stroke, transient ischemic attack (TIA), or peripheral thrombo-embolism. Peri-procedural and mid-term complications were reported. Results: Four-hundred thirty patients (mean age 50.7 ± 13.0 years, 231 men) underwent closure. The indications were cryptogenic stroke (69.8%), TIA (23.5%), peripheral embolism (3.3%), and other (3.5%). The median follow-up time was 0.8 years, range 3.9 years. The primary endpoint occurred in 0.5% for stroke, in 2.5% for TIA, and in none for peripheral embolism. Periprocedural complications were reported in 11.5% of cases, from which 0.2% was defined as major. No severe complications occurred during mid-term follow-up. A residual shunt was present in 12.5% of patients who did not suffer from a recurrent event, compared to 36.4% of patients who reached the primary endpoint (P = 0.04). Conclusion: This multi-centre study suggests that percutaneous closure of a symptomatic PFO with the fourth generation Intrasept device is safe and might be effective to prevent the recurrence of paradoxical thrombo-embolic events.

Original languageEnglish
Pages (from-to)822-828
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Issue number6
Publication statusPublished - May 1 2008


  • Device
  • Intrasept™
  • Patent foramen ovale
  • Transcatheter closure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Outcome after percutaneous closure of a patent foramen ovale using the Intrasept™ device: A multi-centre study'. Together they form a unique fingerprint.

Cite this